Who owns CORCEPT THERAPEUTICS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CORT from SEC Form 13F filings across 423 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 423 institutions disclosed 82.3M shares of CORCEPT THERAPEUTICS INC worth $7.15B — about 78.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
423
13F holders
$7.15B
value, 2026 filers
78.1%
of shares outstanding (82.3M sh)
133
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CORT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 12.4M | $1.08B | 0.0% | 11.8% | +2.3% |
| 2 | INGALLS & SNYDER LLC | 7.9M | $689.9M | 18.8% | 7.5% | +4.3% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 5.3M | $457.5M | 0.6% | 5% | -7.4% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $438.6M | 0.0% | 4.8% | +4.6% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $362.8M | 0.0% | 4% | +2.3% |
| 6 | Parallel Advisors, LLC | 4.0M | $344.5M | 5.3% | 3.8% | -0.4% |
| 7 | FMR LLC | 3.3M | $290.2M | 0.0% | 3.2% | +4.6% |
| 8 | STATE STREET CORP | 3.3M | $285.2M | 0.0% | 3.1% | +2.5% |
| 9 | AQR CAPITAL MANAGEMENT LLC | 2.6M | $224.6M | 0.1% | 2.5% | +535.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $220.2M | 0.0% | 2.4% | -6.7% |
| 11 | FIRST TRUST ADVISORS LP | 1.8M | $159.1M | 0.1% | 1.7% | -15.8% |
| 12 | TANG CAPITAL MANAGEMENT LLC | 1.5M | $130.4M | 5.9% | 1.4% | 0.0% |
| 13 | UBS Group AG | 1.4M | $119.8M | 0.0% | 1.3% | +1.0% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $114.7M | 0.0% | 1.3% | -15.1% |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $100.7M | 0.0% | 1.1% | +3.4% |
| 16 | MORGAN STANLEY | 1.1M | $98.9M | 0.0% | 1.1% | +11.7% |
| 17 | D. E. Shaw & Co., Inc. | 883,001 | $76.8M | 0.0% | 0.8% | -25.3% |
| 18 | Cerity Partners LLC | 797,119 | $69.3M | 0.1% | 0.8% | +8.9% |
| 19 | MPM BIOIMPACT LLC | 771,028 | $67.0M | 4.1% | 0.7% | -21.8% |
| 20 | NORTHERN TRUST CORP | 753,796 | $65.5M | 0.0% | 0.7% | +17.2% |
| 21 | EMERALD ADVISERS, LLC | 748,325 | $65.1M | 1.5% | 0.7% | +264.0% |
| 22 | FULLER & THALER ASSET MANAGEMENT, INC.NEW | 710,106 | $61.7M | 0.2% | 0.7% | new |
| 23 | JACOBS LEVY EQUITY MANAGEMENT, INCNEW | 695,532 | $60.5M | 0.2% | 0.7% | new |
| 24 | VANGUARD FIDUCIARY TRUST CO | 614,078 | $53.4M | 0.0% | 0.6% | +4.0% |
| 25 | TWO SIGMA INVESTMENTS, LP | 610,078 | $53.0M | 0.0% | 0.6% | -35.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.